Using the lower limit of normal for the FEV[sub1]/FVC ratio reduces the misclassification of airway obstruction

Swanney, M. P.; Ruppel, G.; Enright, P. L.; Pedersen, O. F.; Crapo, A. O.; Miller, M. A.; Jensen, R. L.; Falaschetti, E.; Schouten, J. P.; Hankinson, J. L.; Stocks, J.; Quanjer, P. H.
December 2008
Thorax;Dec2008, Vol. 63 Issue 12, p1046
Academic Journal
Aim: The prevalence of airway obstruction varies widely with the definition used. Objectives: To study differences in the prevalence of airway obstruction when applying four international guidelines to three population samples using four regression equations. Methods: We collected predicted values for forced expiratory volume in 1 s/forced vital capacity (FEV[sub1]/FVC) and its lower limit of normal (LLN) from the literature. FEV[sub1]/FVC from 40 646 adults (including 13136 asymptomatic never smokers) aged 17-90+years were available from American, English and Dutch population based surveys. The prevalence of airway obstruction was determined by the LLN for FEV[sub1]/FVC, and by using the Global Initiative for Chronic Obstructive Lung Disease (GOLD), American Thoracic Society/European Respiratory Society (ATS/ERS) or British Thoracic Society (BTS) guidelines, initially in the healthy subgroup and then in the entire population. Results: The LLN for FEV[sub1]/FVC varied between prediction equations (57 available for men and 55 for women), and demonstrated marked negative age dependency. Median age at which the LLN fell below 0.70 in healthy subjects was 42 and 48 years in men and women, respectively. When applying the reference equations (Health Survey for England 1995-1 996, National Health and Nutrition Examination Survey (NHANES) Ill, European Community for Coal and Steel )ECCS)/ERS and a Dutch population study) to the selected population samples, the prevalence of airway obstruction in healthy never smokers aged over 60 years varied for each guideline: 17-45% of men and 7-26% of women for GOLD; 0-18% of men and 0-16% of women for ATS/ERS; and 0-9% of men and 0-11% of women for BTS. GOLD guidelines caused false positive rates of up to 60% when applied to entire populations. Conclusions: Airway obstruction should be defined by FEV[sub1]/FVC and FEV[sub1] being below the LLN using appropriate reference equations.


Related Articles

  • Pulmonary rehabilitation; what's in a name? Singh, Sally J.; Steiner, Michael C. // Thorax;Oct2013, Vol. 68 Issue 10, p899 

    The article offers information on the pulmonary rehabilitation. It mentions that the therapeutic efficacy of rehabilitation is supported by clinical trial evidence. It informs that the place of pulmonary rehabilitation in the management of chronic obstructive pulmonary disease (COPD) and other...

  • Celebrating 25 years of the BTS: the Silver Jubilee Meeting.  // Thorax;May2008, Vol. 63 Issue 5, p392 

    The article reports on topics which were discussed at the 2008 Silver Jubilee year Winter Meeting of the British Thoracic Society, which was held in London, England. Topics included the future of health care delivery, chronic obstructive pulmonary disease and asthma research. The event was...

  • Lung disease: Antioxidant protection against cigarette smoke. Kingwell, Katie // Nature Reviews Drug Discovery;Feb2009, Vol. 8 Issue 2, p110 

    The article discusses the pharmacological activation of nuclear erythroid 2 p45 related factor 2 (NFR2), which controls multiple antioxidative genes. It references a study by Sussan et al in the 2009 issue of "PNAS." It suggests the use of NRF2, a redox-sensitive transcription factor, as an...


    COPD is a disease associated almost exclusively with cigarette smoking. For this reason, suspicion index of COPD in the non-smoker is low, thus making the disease severely underdiagnosed. Therefore, there is the need for both an epidemiological and spirometrical characterisation of the disease...

  • The Relationship between Δ-Forced Vital Capacity (Percent Fall in Forced Vital Capacity at the PC20 Dose of Methacholine) and the Maximal Airway Response in Patients Who Have Mild Asthma. Jinho Yu; Young Yoo; Do Kyun Kim; Young Yull Koh // Allergy & Asthma Proceedings;Sep/Oct2005, Vol. 26 Issue 5, p366 

    Airway hypersensitivity is routinely evaluated by measuring the concentration (PC20) of inhaled methacholine or histamine that causes a 20% fall in forced expiratory volume in 1 second (FEV1). It has been suggested that a percentage fall in forced vital capacity (FVC) measured at the PC20 dose...

  • Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma. Houghton, Catherine M.; Lawson, Naomi; Borrill, Zoe L.; Wixon, Claire L.; Yoxall, Sally; Langley, Stephen J.; Woodcock, Ashley; Singh, Dave // Respiratory Research;2007, Vol. 8, p52 

    Background: This study compared the effect of inhaled fluticasone propionate (FP) with the combination of salmeterol/fluticasone propionate (SFC) on lung function parameters in patients with mild asthma. Methods: Adult patients with mild persistent asthma (≥ 80% predicted FEV1) receiving...

  • Soluble receptor for advanced glycation end-products and progression of airway disease. Iwamoto, Hiroshi; Gao, Jing; Pulkkinen, Ville; Toljamo, Tuula; Nieminen, Pentti; Mazur, Witold // BMC Pulmonary Medicine;2014, Vol. 14 Issue 1, p1 

    Background The receptor for advanced glycation end-products (RAGE) is highly expressed in the lung, where it is believed to have a homeostatic role. Reduced plasma levels of soluble RAGE (sRAGE) have been reported in patients with chronic obstructive pulmonary disease (COPD). The aim of the...

  • AIRWAYS DISEASE: ASPECTS OF ASSESSMENT AND TREATMENT.  // Thorax;Dec2001 Supp, Vol. 56, piii24 

    This article presents various studies related to the airways disease. The measurement of physical performance and domestic activity is important in the evaluation of the effectiveness of rehabilitation in chronic obstructive pulmonary disease (COPD). A number of measurement tools exist for the...

  • Hospital-at-home guidance.  // Practice Nurse;11/24/2006, Vol. 32 Issue 9, p7 

    The article reports on a guideline that was issued by the British Thoracic Society regarding hospital-at-home care for patients with chronic obstructive pulmonary disease in Great Britain. It is said that hospital-at-home is a specific sub-type of intermediate care, where active treatment is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics